Applications of NMR spectroscopy to study muscle glycogen metabolism in man

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 277-290

  Roden, M ^a   Shulman, G I ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Glucose; Glucose 6 phosphate; Insulin resistance; Stable isotopes

Indexed keywords

FATTY ACID; GLUCOSE 6 PHOSPHATE; GLYCOGEN; INSULIN;

CARBON NUCLEAR MAGNETIC RESONANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN METABOLISM; GLYCOGEN MUSCLE LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW;

CARBON ISOTOPES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE-6-PHOSPHATE; GLYCOGEN; HUMANS; INSULIN; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; MUSCLE, SKELETAL; OBESITY; PHOSPHORUS ISOTOPES; PHOSPHORYLATION;

EID: 0033050848     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.277     Document Type: Review

References (56)

1. 1. Shulman GI, Alger JR, Prichard JW, et al. 1984. Nuclear magnetic resonance spectroscopy in diagnostic and investigative medicine. J. Clin. Invest. 74: 1127-31
2. 2. Rothman DL, Shulman RG, Shulman GI. 1991. NMR studies of muscle glycogen synthesis in normal and non-insulin-dependent diabetic subjects. Biochem. Soc. Trans. 19:992-94
3. 3. Radda GK. 1992. Control, bioenergetics, and adaptation in health and disease: noninvasive biochemistry from nuclear magnetic resonance. FASEB J. 6:3032-38
4. 4. Seelig J, Burlina AP. 1992. Carbon-13 magnetic resonance in biology and medicine. Clin. Chem. Acta 206:125-36
5. 5. Taylor R, Shulman GI. 1994. New insights into human carbohydrate metabolism using nuclear magnetic resonance spectroscopy. In The Diabetes Annual, ed. SM Marschall, PD Home, 8:157-75. Amsterdam: Elsevier
6. 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Magn. Reson. Q. 10:43-63
7. 7. Radda GK. 1996. Control of energy metabolism during muscle contraction. Diabetes 45:S88-92 (Suppl. 1)
8. 8. Shulman RG, Rothman DL, Price TB. 1996. Nuclear magnetic resonance studies of muscle and applications to exercise and diabetes. Diabetes 45:S93-98 (Suppl. 1)
9. 9. Gadian DG. 1982. Nuclear Magnetic Resonance and Its Applications to Living Systems, ed. DG Gadian. Oxford: Clarendon
10. 13C NMR: comparison of normal volunteers with a patient. Magn. Reson. Med. 16:150-60
11. 31P magnetic resonance. J. Biol. Chem. 248:7276-78
12. 13C NMR spectrum of glycogen in humans. Magn. Reson. Med. 5:377-79
13. 13C NMR. Proc. Natl. Acad. Sci. USA 85:1634-36
14. 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med 322: 223-28
15. 13C NMR. Science 254:573-76
16. 13C nuclear magnetic resonance spectroscopy. Hepatology 24:114-17
17. 13C NMR visibility of rabbit muscle glycogen in vivo. Magn. Reson. Med. 20:327-32
18. 13C NMR measurements of liver glycogen in vivo. Magn. Reson. Med 31:583-88
19. 13C NMR measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples. Magn. Reson. Med. 27: 13-20
20. 31P NMR measurement of glucose 6 phosphate in the rat muscle after exercise. Magn. Reson. Med. 30:347-50
21. 21. Wolfe RR, ed. 1992. Radioactive and Stable Isotope Tracers in Biomedicine. New York: Wiley-Liss
22. 22. Edwards RH, Dawson MJ, Wilkie DR, et al. 1982. Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet i:725-31
23. 23. Rossetti L, Giaccari A. 1990. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J. Clin. Invest. 85:1785-92
24. 24. DeFronzo RA. 1988. The triumvirate: b cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-87
25. 25. DeFronzo RA, Jacot E, Jequier E, et al. 1981. The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-7
26. 26. Bogardus C, Thuillez P, Ravussin E, et al. 1983. Effect of muscle glycogen depletion on in vivo insulin action in man. J. Clin. Invest. 72:1605-10
27. 27. Taylor R, Price TB, Katz LD, et al. 1993. Direct measurements of change in muscle glycogen concentrations after a mixed meal in normal subjects. Am. J. Physiol. 265:E224-29
28. 28. Olefsky JM, Kolterman OG, Scarlett JA. 1982. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am. J. Physiol. 243:E15-30
29. 29. Reaven GM. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
30. 30. Scheen AJ, Paquot N, Letiexhe MR, et al. 1995. Glucose metabolism in obese subjects: lessons learned from OGTT, IVGTT and clamp studies. Int. J. Obesity 19: S14-20(Suppl. 3)
31. 31. Beck-Nielsen H, Groop LC. 1994. Metabolic and genetic characterization of prediabetic states. J. Clin. Invest. 94:1714-21
32. 32. Warram JH, Martin BC, Krolewski AS, et al. 1990. Slow glucose removal rate and hyperinsulinemia precede the development of Type II diabetes in the offspring of diabetic parents. Ann. Int. Med. 113:909-15
33. 33. Roch-Norlund AE, Bergstromm J, Hultman E. 1972. Muscle glycogen and glycogen synthethase in normal subjects and in patients with diabetes mellitus: effect of intravenous glucose and insulin administration. Scand. J. Clin. Lab. Invest. 30:77-84
34. 34. Bogardus C, Lillioja S, Mott D, et al. 1984. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J. Clin. Invest. 73:800-5
35. 35. Garvey WT, Maianu L, Huecksteadt TP, et al. 1991. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J. Clin. Invest. 87:1072-81
36. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89:1069-75
37. 37. Yki-Järvinen H, Helve E, Koivisto VA. 1987. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 36: 892-96
38. 38. Rossetti L, Giaccari A, DeFronzo RA. 1990. Glucose toxicity. Diabetes Care 13:610-30
39. 39. Marshall S, Bacote V, Traxinger R. 1991. Discovery of a metabolic pathway mediating glucose-induced desensitization of glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266:4706-12
40. 40. Baron A, Zhu JS, Zhu JH, et al. 1995. Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle. J. Clin. Invest. 96:2792-2801
41. 41. Rossetti L, Smith D, Shulman GI, et al. 1987. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79:1510-15
42. 42. Rothman DL, Magnusson I, Cline G, et al. 1995. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 92:983-87
43. 43. Perseghin G, Price TB, Petersen KF, et al. 1996. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N. Engl. J. Med. 335: 1357-62
44. 31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes 47:381-86
45. 45. Golay A, Munger R, Felber J-P. 1997. Obesity and NIDDM: the retrograde regulation concept. Diabetes Rev. 5:69-82
46. 46. Felber JP, Ferrannini E, Golay A, et al. 1987. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-50
47. 47. Bonadonna RC, Bonora E. 1997. Glucose and free fatty acid metabolism in human obesity. Relationships to insulin resistance. Diabetes Rev. 5:21-51
48. 48. Gulli G, Ferrannini E, Stern S, et al. 1992. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575-86
49. 49. Perseghin G, Ghosh S, Gerow K, et al. 1997. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-9
50. 50. Randle PJ, Garland PB, Hales CN, et al. 1963. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-89
51. 51. Randle PJ, Garland PB, Newsholme EA, et al. 1965. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann. NY Acad. Sci. 131:324-33
52. 52. Roden M, Price TB, Perseghin G, et al. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97:2859-65
53. 53. Ferrannini E, Barrett EJ, Bevilacqua A, et al. 1983. Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 72:1737-47
54. 54. Yki-Järvinen H, Puhakainen I, Koivisto VA. 1991. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J. Clin. Endocrinol. Metab. 72:1268-77
55. 55. Boden G, Chen X, Ruiz J, et al. 1994. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93:2438-46
56. 56. Cline GW, Magnusson I, Rothman DL, et al. 1997. Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus. J. Clin. Invest. 99:2219-24